Vaylen vs MedVi: Compounded Semaglutide Pricing and Process
Quick verdict: For lower prepaid monthly pricing and choice of oral or tirzepatide formats, Vaylen is the better cash-pay value; for a no-contract, promotional first month and 24/7 support, MedVi is the simpler entry. This comparison of Vaylen vs MedVi focuses on pricing, treatment options, clinician workflow, support, and refund or promo terms.
Start with Vaylen pricing and formats
Key difference 1: Pricing model and headline rates
Vaylen publishes annualized, prepaid headline rates: semaglutide injections from $83.25/mo on a 12-month plan (billed upfront), oral semaglutide at $99/mo on the 12-month plan, and tirzepatide from $149/mo on a 12-month plan. Those 12-month rates require prepaying a single charge. MedVi advertises a promotional first month at $179 including fast, free shipping; after the first month a standalone month is $299 and a three-month plan is $649 (about $216/mo). Both providers operate on cash-pay terms and both use compounded medications.
Key difference 2: Treatment options and molecule variety
Vaylen offers three formats across two molecules: weekly semaglutide injections, daily oral semaglutide tablets, and weekly tirzepatide injections. MedVi offers clinically dosed compounded semaglutide only. If access to tirzepatide or a needle-free oral semaglutide is important, Vaylen supports those formats; if you only want semaglutide, MedVi focuses on that single molecule.
See Vaylen format options and prices
Key difference 3: Clinician workflow, timing, and entry process
Vaylen requires prepayment before clinician review; it says a board-certified U.S. clinician reviews the health form within 24 hours and that a full refund is issued for that billing cycle if the clinician declines to prescribe. MedVi describes a simple online intake with no clinic visits and states an OpenLoop Health clinician will meet with an individual after checkout; MedVi locks refills at its full price after the promotional first month. Both platforms state licensed clinicians determine eligibility and both note compounded medications are not FDA-approved finished products.
Begin MedVi with the promotional first month
Key difference 4: Support, shipping, and guarantees
Vaylen advertises $0 consultation fee, clinician review within 24 hours, free discreet shipping in 1 to 3 business days, and a published full refund if not approved. MedVi highlights 24/7 support from certified medical professionals, fast free shipping for the promo month, and no clinic visits required. MedVi also notes program benefits tied to physician review, personalized plans, and that results on the platform may vary and depend on clinician decisions and patient adherence.
Comparison table: Vaylen vs MedVi
| Criteria | Vaylen | MedVi |
|---|---|---|
| Starting price | Semaglutide from $83.25/mo on 12-month plan; $224/mo month-to-month | Promotional first month $179; standalone month $299 |
| Molecule options | Semaglutide injectable, oral semaglutide tablet, tirzepatide injectable | Compounded semaglutide only |
| Payment timing | Prepay full 12-month charge before clinician review; refund if declined | No-contract first month promo; refills locked at full price thereafter |
| Clinician review | Board-certified U.S. clinician reviews within 24 hours | OpenLoop Health clinicians review after checkout; online intake, no clinic visit |
| Support & shipping | Free discreet shipping in 1 to 3 business days; 24/7 care-team messaging included | Fast, free shipping for promo; 24/7 certified medical support |
| Regulatory note | Compounded medications not FDA-approved finished products | Compounded medications not FDA-approved finished products |
How outcomes and claims are presented
Vaylen cites average body-weight figures for semaglutide and tirzepatide on its pages and repeats a refund if not approved. MedVi references self-reported patient data over six months and states results vary based on adherence, with typical weight changes described in marketing language. Both platforms disclose that compounded medications are not FDA-evaluated finished products and that clinician judgment determines prescriptions.
Final comparison and short conclusion
In direct comparison, Vaylen vs MedVi splits on cost structure and product breadth: Vaylen is built around prepaid 12-month pricing with multiple formats including oral semaglutide and tirzepatide, plus a stated refund if a clinician declines; MedVi emphasizes a low first-month promotional rate, a simple online intake with no clinic visits, and 24/7 certified support but only semaglutide and higher ongoing monthly rates. The primary keyword Vaylen vs MedVi captures that tradeoff: lower prepaid monthly rates and more format choices at Vaylen, simpler promo entry and ongoing support at MedVi.
Compare MedVi’s promo and support
Choose Vaylen if…
- You want the lowest advertised effective monthly rate on a prepaid 12-month plan and the option of oral semaglutide or tirzepatide.
- You are comfortable prepaying a single annual charge before clinician review and value a published full refund if a clinician declines to prescribe.
Choose MedVi if…
- You want a no-clinic-visit, no-contract entry with a promotional first month at $179 and 24/7 certified medical support.
- You prefer to start on a promotional month and evaluate ongoing cost later, and you only need semaglutide.